HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

TECH

Bio-Techne Corp

Last Close
Jan 02  •  04:00PM ET
59.65
Dollar change
+0.84
Percentage change
1.43 %
Healthcare • Biotechnology • USA • NASD
Peers: TMO DHR ILMN A BIO QGEN NEO MTD
 | Held by: VTI VOO VB RSP VBK IVV SPY IBB XLV IWR
Scroll to Statements
IndexS&P 500 P/E121.93 EPS (ttm)0.49 Insider Own1.20% Shs Outstand155.75M Perf Week0.78%
Market Cap9.29B Forward P/E26.94 EPS next Y2.21 Insider Trans-1.79% Shs Float153.94M Perf Month-5.24%
Enterprise Value9.54B PEG2.68 EPS next Q0.43 Inst Own104.94% Short Float6.12% Perf Quarter-3.93%
Income77.95M P/S7.64 EPS this Y3.36% Inst Trans1.43% Short Ratio4.76 Perf Half Y12.25%
Sales1.22B P/B4.73 EPS next Y11.56% ROA2.96% Short Interest9.41M Perf YTD1.43%
Book/sh12.62 P/C64.12 EPS next 5Y10.06% ROE3.80% 52W High79.28 -24.76% Perf Year-17.49%
Cash/sh0.93 P/FCF41.48 EPS past 3/5Y-34.80% -20.58% ROIC3.32% 52W Low46.01 29.65% Perf 3Y-27.44%
Dividend Est.0.32 (0.54%) EV/EBITDA25.62 Sales past 3/5Y3.33% 10.55% Gross Margin66.79% Volatility1.68% 2.85% Perf 5Y-25.81%
Dividend TTM0.32 (0.54%) EV/Sales7.84 EPS Y/Y TTM-48.17% Oper. Margin21.89% ATR (14)1.61 Perf 10Y165.47%
Dividend Ex-DateNov 17, 2025 Quick Ratio2.81 Sales Y/Y TTM3.85% Profit Margin6.41% RSI (14)50.02 Recom1.63
Dividend Gr. 3/5Y0.00% 0.00% Current Ratio4.22 EPS Q/Q17.12% SMA200.60% Beta1.47 Target Price69.67
Payout69.67% Debt/Eq0.20 Sales Q/Q-1.00% SMA50-1.74% Rel Volume0.98 Prev Close58.81
Employees3100 LT Debt/Eq0.19 EarningsNov 05 BMO SMA2008.15% Avg Volume1.98M Price59.65
IPOFeb 09, 1989 Option/ShortYes / Yes EPS/Sales Surpr.-0.33% -1.63% Trades Volume1,941,700 Change1.43%
Date Action Analyst Rating Change Price Target Change
Sep-03-25Upgrade RBC Capital Mkts Sector Perform → Outperform $73
Aug-21-25Upgrade Citigroup Neutral → Buy $70
Jul-22-25Resumed Stephens Overweight $65
Jul-09-25Initiated TD Cowen Buy $65
May-30-25Initiated Wells Fargo Overweight $59
Apr-09-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-18-25Initiated Evercore ISI Outperform $75
Feb-19-25Downgrade Robert W. Baird Outperform → Neutral $88 → $68
May-22-24Downgrade Citigroup Buy → Neutral $85
Feb-08-24Initiated Scotiabank Sector Outperform $80
Show Previous Ratings
Jan-03-26 07:20AM
Klaviyo, Wingstop among Stephens Best Ideas for 2026
(TipRanks)
Dec-30-25 10:34PM
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH)
(StockStory)
Dec-23-25 07:00AM
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
(PR Newswire)
Dec-22-25 09:17AM
Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?
(Zacks)
Dec-16-25 07:40AM
Bio-Techne Stock: Is TECH Underperforming the Healthcare Sector?
(Barchart)
09:36AM Loading…
Dec-11-25 09:36AM
Here's Why BioTechne (TECH) Traded Lower in Q3
(Insider Monkey)
06:30AM
Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
(PR Newswire)
Dec-09-25 06:30AM
Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
(PR Newswire)
Dec-04-25 10:29AM
Bio-Techne Corporation (TECH): A Bull Case Theory
(Insider Monkey)
Nov-25-25 07:00AM
Bio-Techne to Present at Upcoming Investor Conferences
(PR Newswire)
Nov-18-25 06:30AM
Bio-Techne Licenses AI-Designed NovoBody Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
(PR Newswire)
Nov-13-25 11:28PM
Bio-Techne Stock: Is Wall Street Bullish or Bearish?
(Barchart)
09:01AM
Is Bio-Techne Corporation (TECH) a High-Quality Growth-Oriented Compounder Within The Healthcare Sector?
(Insider Monkey)
Nov-11-25 03:55PM
Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
(StockStory)
Nov-07-25 05:36PM
McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More.
(Barrons.com)
07:00AM Loading…
Nov-06-25 07:00AM
Bio-Techne to Present at Upcoming Investor Conferences
(PR Newswire)
Nov-05-25 09:57PM
Analyst Report: Bio-Techne Corporation
(Morningstar Research)
04:03PM
Bio-Techne Corp (TECH) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
(GuruFocus.com)
10:52AM
TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up
(Zacks)
09:30AM
Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings
(Zacks)
07:40AM
Techne (TECH) Meets Q1 Earnings Estimates
(Zacks)
06:38AM
Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops
(StockStory)
06:30AM
Bio-Techne Releases First Quarter Fiscal 2026 Results
(PR Newswire)
06:30AM
BIO-TECHNE DECLARES DIVIDEND
(PR Newswire)
Nov-04-25 09:01AM
AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients
(PR Newswire)
Nov-03-25 10:17PM
What To Expect From Bio-Techne's (TECH) Q3 Earnings
(StockStory)
07:00AM
ScaleReady Announces a G-Rex Grant has been awarded to Sonoma Biotherapeutics
(PR Newswire)
Oct-31-25 03:21PM
Why Bio-Techne (TECH) Stock Is Up Today
(StockStory)
Oct-30-25 07:27PM
Analyst Report: Bio-Techne Corporation
(Morningstar Research)
Oct-29-25 10:00AM
Techne (TECH) Reports Next Week: What to Know Ahead of the Release
(Zacks)
06:30AM Loading…
Oct-28-25 06:30AM
Bio-Techne Launches ProximityScope Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
(PR Newswire)
Oct-23-25 06:56PM
Analyst Report: Bio-Techne Corporation
(Morningstar Research)
07:54AM
Bio-Techne Q1 Earnings Preview: What's in Store for the Stock?
(Zacks)
07:00AM
ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at Children's National Hospital
(PR Newswire)
Oct-16-25 12:04AM
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
(StockStory)
Oct-15-25 09:00AM
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
(Business Wire)
07:00AM
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
(PR Newswire)
Oct-14-25 11:40AM
GMAB or TECH: Which Is the Better Value Stock Right Now?
(Zacks)
08:48AM
Earnings Preview: What to Expect From Bio-Techne's Report
(Barchart)
Oct-09-25 07:00AM
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
(PR Newswire)
Oct-08-25 08:18AM
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
(Zacks)
Oct-03-25 04:16PM
S&P 500 Stocks: These 5 Lead As Index Hits Record High
(Investor's Business Daily)
Sep-30-25 04:00PM
Bio-Techne (TECH) Shares Skyrocket, What You Need To Know
(StockStory) +6.51% +7.71%
Sep-29-25 08:22AM
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
(Zacks)
Sep-26-25 06:30AM
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
(PR Newswire)
Sep-24-25 07:28AM
BioTechne (TECH) Fell Over the Industry's Uncertain Funding Environment
(Insider Monkey)
07:15AM
Is Bio-Techne Stock Underperforming the Dow?
(Barchart)
06:59AM
Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
(PR Newswire)
Sep-19-25 09:31AM
Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?
(Zacks)
Sep-16-25 11:31PM
Research Tools & Consumables Stocks Q2 Highlights: Bio-Techne (NASDAQ:TECH)
(StockStory)
Sep-15-25 09:28AM
Here's Why The Brown Capital Small Company Fund is Re-Evaluating Bio-Techne's (TECH) Long-Term Growth Profile
(Insider Monkey)
Sep-10-25 03:11PM
Why Bio-Techne (TECH) Stock Is Down Today
(StockStory) -5.98%
Sep-09-25 04:05PM
CONMED Corporation Adds Kim Kelderman to its Board of Directors
(Business Wire)
07:00AM
ScaleReady Awards G-Rex Grants to Support Cell and Gene Therapy Manufacturing in California
(PR Newswire)
Sep-02-25 02:26PM
Why Bio-Techne (TECH) Shares Are Sliding Today
(StockStory)
Aug-27-25 07:00AM
Bio-Techne to Present at Upcoming Investor Conferences
(PR Newswire)
Aug-22-25 03:40PM
Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know
(StockStory) +5.72%
Aug-21-25 09:36AM
CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls
(The Fly)
Aug-19-25 07:57AM
Bio-Techne Stock: Analyst Estimates & Ratings
(Barchart)
Aug-14-25 07:00AM
ScaleReady Announces Award of a G-Rex Grant to the Gates Institute's Translational Sciences Laboratory
(PR Newswire)
Aug-13-25 01:35AM
The 5 Most Interesting Analyst Questions From Bio-Techne's Q2 Earnings Call
(StockStory)
Aug-12-25 03:17AM
TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty
(StockStory) +5.34%
Aug-11-25 02:56PM
Analyst Report: Bio-Techne Corporation
(Morningstar Research)
Aug-06-25 01:20PM
Why Bio-Techne (TECH) Shares Are Plunging Today
(StockStory) -8.73%
09:31AM
Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations
(StockStory)
09:30AM
Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings
(Zacks)
09:05AM
Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls
(Zacks)
07:50AM
Techne (TECH) Beats Q4 Earnings and Revenue Estimates
(Zacks)
06:30AM
Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
(PR Newswire)
06:30AM
BIO-TECHNE DECLARES DIVIDEND
(PR Newswire)
Aug-05-25 04:30PM
Bio-Techne Announces Exosome Diagnostics Divestiture
(PR Newswire)
07:00AM
ScaleReady Announces a G-Rex Grant has been awarded to Sidra Medicine
(PR Newswire)
Aug-04-25 11:19PM
Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow
(StockStory)
09:51AM
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
(Zacks)
Aug-01-25 08:13AM
Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending
(Insider Monkey)
07:46AM
Bio-Techne Corporation (TECH) Slid on Rise in Investors' Concerns
(Insider Monkey)
Jul-31-25 07:00AM
ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
(PR Newswire) -5.16%
Jul-30-25 12:03AM
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
(StockStory)
Jul-28-25 02:07AM
Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen
(Insider Monkey)
Jul-24-25 04:07PM
Bio-Techne Corporation (TECH): A Bull Case Theory
(Insider Monkey) +5.71%
Jul-22-25 02:05PM
Bio-Techne (TECH) Stock Is Up, What You Need To Know
(StockStory) +5.67%
Jul-18-25 01:03AM
Bio-Technes Quarterly Earnings Preview: What You Need to Know
(Barchart)
Jul-17-25 07:00AM
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
(PR Newswire)
Jul-16-25 11:40AM
INCY or TECH: Which Is the Better Value Stock Right Now?
(Zacks)
Jul-15-25 10:09AM
Here's Headwaters Capital Management's Investment Thesis for Bio-Techne (TECH)
(Insider Monkey)
09:03AM
Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
(Business Wire)
07:00AM
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
(PR Newswire)
Jul-14-25 07:00AM
Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene Therapy
(PR Newswire)
Jul-09-25 01:33AM
5 Revealing Analyst Questions From Bio-Techne's Q1 Earnings Call
(StockStory)
Jun-30-25 08:49AM
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock
(Zacks)
Jun-25-25 04:46PM
Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development
(Insider Monkey)
08:44AM
Is Bio-Techne Stock Underperforming the Nasdaq?
(Barchart)
Jun-24-25 07:00AM
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
(PR Newswire)
Jun-10-25 01:15PM
TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts
(StockStory)
07:00AM
ScaleReady Announces a G-Rex Grant has been awarded to Immuneel Therapeutics
(PR Newswire)
Jun-06-25 04:08PM
Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?
(MarketWatch)
11:31AM
Why Is Techne (TECH) Down 3% Since Last Earnings Report?
(Zacks)
Jun-02-25 11:33PM
Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1
(StockStory)
May-30-25 12:47AM
Bio-Techne Corporation (TECH): A Bull Case Theory
(Insider Monkey)
May-29-25 08:47AM
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
(Zacks)
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hippel JamesCFONov 03 '25Option Exercise0.0024,7040154,587Nov 05 04:46 PM
Geist WilliamPRESIDENT, PROTEIN SCIENCESNov 03 '25Option Exercise0.009,911025,023Nov 05 04:46 PM
Nusse RoelandDirectorAug 25 '25Option Exercise21.8417,040372,15461,599Aug 27 04:10 PM
Nusse RoelandDirectorAug 25 '25Sale56.3617,040960,38844,559Aug 27 04:10 PM
BAUMGARTNER ROBERT VDirectorAug 25 '25Option Exercise21.8417,040372,15461,903Aug 27 04:09 PM
BAUMGARTNER ROBERT VDirectorAug 25 '25Sale56.2117,040957,81844,863Aug 27 04:09 PM
ROELAND NUSSEDirectorAug 25 '25Proposed Sale56.3617,040960,388Aug 25 04:05 PM
ROBERT V. BAUMGARTNER4731 BONIDirectorAug 25 '25Proposed Sale56.2117,040957,849Aug 25 04:04 PM
Hippel JamesCFOAug 15 '25Option Exercise0.004,0100131,809Aug 19 05:38 PM
Herr Amy E.DirectorAug 15 '25Option Exercise0.0027902,255Aug 19 05:29 PM
Kelderman KimChief Executive OfficerAug 15 '25Option Exercise0.008,543055,273Aug 19 05:28 PM
Bohnen ShaneSVP - General CounselAug 15 '25Option Exercise0.001,71804,912Aug 19 05:28 PM
McManus MatthewPresident - Diag & Spatial BioAug 15 '25Option Exercise0.002,63705,615Aug 19 05:28 PM
Geist WilliamPRESIDENT, PROTEIN SCIENCESAug 15 '25Option Exercise0.002,623015,915Aug 19 05:27 PM
HIGGINS JOHN LDirectorAug 07 '25Option Exercise21.845,040110,07465,236Aug 11 07:06 PM
Hippel JamesCFOJul 29 '25Option Exercise44.33168,6207,474,925275,230Jul 31 04:28 PM
Kelderman KimChief Executive OfficerJul 22 '25Option Exercise44.3348,1762,135,64290,379Jul 24 04:26 PM
Kelderman KimChief Executive OfficerJul 15 '25Option Exercise44.3336,1321,601,73275,136Jul 17 05:04 PM
Herr Amy E.DirectorJun 09 '25Option Exercise44.331,28056,7423,256Jun 11 04:20 PM
Herr Amy E.DirectorJun 09 '25Sale49.771,28063,7051,976Jun 11 04:20 PM
JOSHUA MOLHOOfficerJun 09 '25Proposed Sale49.771,28063,705Jun 09 04:19 PM
HIGGINS JOHN LDirectorMay 01 '25Option Exercise21.8412,000262,08060,196May 05 04:18 PM
Bohnen ShaneSVP - General CounselApr 03 '25Option Exercise0.002,26003,941Apr 07 04:25 PM
Herr Amy E.DirectorFeb 14 '25Option Exercise44.331,97687,5963,836Feb 18 04:49 PM
Herr Amy E.DirectorFeb 14 '25Sale65.961,860122,6911,976Feb 18 04:49 PM
JOSHUA MOLHODomestic Partner of Director Feb 14 '25Proposed Sale65.961,860122,691Feb 14 04:08 PM
McManus MatthewPresident - DGSFeb 01 '25Option Exercise0.004,62004,620Feb 04 05:31 PM
Geist WilliamPRESIDENT, PROTEIN SCIENCESFeb 01 '25Option Exercise0.003,320014,401Feb 04 05:27 PM
Kelderman KimChief Executive OfficerJan 27 '25Option Exercise37.7013,392504,87852,396Jan 29 04:35 PM
Kelderman KimChief Executive OfficerJan 27 '25Sale77.2913,3921,035,01339,004Jan 29 04:35 PM
KIM KELDERMANDirectorJan 27 '25Proposed Sale77.0513,3921,031,854Jan 27 04:24 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.